Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing Sodium Reduction Strategy: Context-Specific Frameworks Targeting Main Dietary Sources.

Advances in nutrition (Bethesda, Md.)·2026
Same author

Design considerations for hypertension chronotherapy trials: insights from experience and modelling.

BMC medicine·2026
Same author

Dietary Sodium Reduction: Concerns regarding systematic selection of evidence.

European journal of preventive cardiology·2026
Same author

Lower-sodium salt substitutes: premature public health strategy or promising adjunct?

Journal of hypertension·2026
Same author

The effect of plant-based dietary patterns on C-reactive protein: A systematic review and meta-analysis of randomised controlled trials.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Adherence to the Mediterranean Diet and Dietary Potassium Intake: A Narrative Review of Epidemiological Evidence.

Nutrients·2026
Same journal

Why current evidence does not support routine C5 inhibition in STEC-HUS.

Kidney international·2026
Same journal

Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
See all related articles

Related Experiment Videos

Does reducing salt intake increase cardiovascular mortality?

Feng J He1, Lawrence J Appel, Francesco P Cappuccio

  • 1Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. f.he@qmul.ac.uk

Kidney International
|August 5, 2011
PubMed
Summary
This summary is machine-generated.

Reducing dietary salt intake lowers blood pressure and prevents cardiovascular disease. Recent flawed studies questioning salt reduction benefits are refuted, maintaining its public health priority for non-communicable diseases.

Related Experiment Videos

Area of Science:

  • Cardiovascular health
  • Public health and epidemiology
  • Nutrition science

Background:

  • Established evidence links high salt intake (9-12 g/d) to elevated blood pressure and cardiovascular disease (CVD).
  • Dietary salt reduction to 5-6 g/d is a proven strategy for blood pressure control and CVD prevention.
  • The World Health Organization (WHO) designates salt reduction as critical for addressing the global non-communicable disease crisis.

Discussion:

  • A recent study's claim of higher cardiovascular mortality with lower salt intake despite reduced blood pressure is critically evaluated.
  • The methodology and conclusions of the recent study are identified as flawed, failing to invalidate the established benefits of salt reduction.
  • The public health imperative for population-wide salt reduction strategies is reinforced.

Key Insights:

  • Overwhelming scientific consensus supports salt reduction for cardiovascular health.
  • Flawed research should not undermine established public health recommendations.
  • Salt reduction remains a vital strategy for preventing non-communicable diseases globally.

Outlook:

  • Continued emphasis on public health initiatives promoting reduced salt consumption is essential.
  • Further research should focus on robust methodologies to confirm the benefits of salt reduction.
  • Global efforts to decrease population salt intake are crucial for long-term cardiovascular disease prevention.